All trials View full record on ClinicalTrials.gov
NCT05552157PHASE2RECRUITING
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Eligibility check — Phoenix members
Phoenix members see for THIS trial:
- APOE genotype match
- Cognitive status fits inclusion
- Specific exclusions flagged
- Distance to nearest site
Sites
35 locations
Start
2024-11-22
Interventions tested
- DRUGRemternetug (SC)
- DRUGMatching Placebo (Remternetug)